PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 50 filers reported holding PASSAGE BIO INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $190 | -17.4% | 288 | +18.0% | 0.00% | – |
| Q2 2023 | $230 | -55.0% | 244 | -54.3% | 0.00% | – |
| Q1 2023 | $511 | +61.2% | 534 | +132.2% | 0.00% | – |
| Q4 2022 | $317 | -68.3% | 230 | -63.1% | 0.00% | – |
| Q3 2022 | $1,000 | -50.0% | 624 | -1.9% | 0.00% | – |
| Q2 2022 | $2,000 | -80.0% | 636 | -80.2% | 0.00% | – |
| Q1 2022 | $10,000 | -90.5% | 3,213 | -80.5% | 0.00% | – |
| Q4 2021 | $105,000 | +1650.0% | 16,454 | +2584.2% | 0.00% | – |
| Q3 2021 | $6,000 | 0.0% | 613 | +25.6% | 0.00% | – |
| Q2 2021 | $6,000 | -68.4% | 488 | -53.9% | 0.00% | – |
| Q1 2021 | $19,000 | -92.3% | 1,058 | -89.1% | 0.00% | – |
| Q4 2020 | $248,000 | +376.9% | 9,724 | +144.9% | 0.00% | – |
| Q3 2020 | $52,000 | -72.5% | 3,971 | -42.7% | 0.00% | – |
| Q2 2020 | $189,000 | – | 6,929 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 4,959,769 | $6,844,481 | 14.16% |
| Lynx1 Capital Management LP | 3,355,917 | $4,631,165 | 4.00% |
| New Leaf Venture Partners, L.L.C. | 2,497,922 | $3,447,132 | 2.50% |
| BML Capital Management, LLC | 337,467 | $465,704 | 0.44% |
| Frazier Life Sciences Management, L.P. | 3,756,915 | $5,184,543 | 0.32% |
| Orbimed Advisors | 8,931,999 | $12,326,159 | 0.24% |
| Newtyn Management, LLC | 790,000 | $1,090,200 | 0.22% |
| Oasis Management Co Ltd. | 240,000 | $331,200 | 0.07% |
| Rubric Capital Management LP | 822,105 | $1,134,505 | 0.05% |
| Marquette Asset Management, LLC | 67,101 | $92,599 | 0.03% |